The first win for 'Xarelto Plaintiff'
The first win for 'Xarelto Plaintiff'
Introduction
The first Philadelphia Xarelto bellwether trial, convened in the Philadelphia's Complex Litigation Center, not only went in favor of the plaintiff but also was the first win for a 'Xarelto Plaintiff' after three straight losses in the federal court. In response to the plaintiff's allegations that Xarelto caused severe bleeding after being prescribed by her doctor and inadequate warnings provided by the drug makers, the state court jury awarded $29 million in damages against the defendants Johnson & Johnson and Bayer AG.
Xarelto lawsuits are centralized in the U.S. District Court for the Eastern District of Louisiana before Judge Eldon E. Fallon as a part of MDL- 2592 Xarelto Products Liability Litigation. Currently, more than 22,000 Xarelto cases are pending in several courts across the country. With the first win proving that a Xarelto prescription caused internal bleeding and no adequate warnings provided by the manufacturers, preparation will begin for the remaining Xarelto cases.
Comments
Latest News
Supreme Court Upholds Flavored Vape Ban
Categories: E-Cigarette: JUUL
The U.S. Supreme Court has unanimously upheld a decision by the Food and Drug Administration (FDA) to block the sale and marketing of certain flavored e-cigarette products.
The ruling supports the FDA’s authority to regulate tobacco…
Judge Rejects JnJ's $10B Talc Lawsuit Settlement
Categories: Talcum
Johnson & Johnson's shares fell more than 5% after a U.S. bankruptcy judge rejected its $10 billion settlement proposal aimed at resolving over 60,000 lawsuits.
These lawsuits allege that the company’s…
Tepezza Hearing Loss MDL: Bellwether Trials Set for 2026
Categories: Tepezza
A U.S. District Judge overseeing Tepezza hearing damage lawsuits nationwide has scheduled four bellwether trials for 2026. These trials are intended to help both parties assess how juries may respond to the evidence and testimonies that could be…